The four anti-CD20 drugs used in the U.S. to treat relapsing MS -- ocrelizumab, ofatumumab, and ublituximab (Briumvi; ...

The risk of MS is significantly higher in people with a specific gene variant called HLA-E*01:01 and a history of mono, a ...

TL;DR: Is your PC in need of a good reboot? Give it a whole new set of tools with a license for Microsoft Office Professional Plus 2019 for Windows, now $29.97 (reg. $229) through April 27.

Almost a year after its introduction, Microsoft is relaunching Recall and adding an improved Windows Search feature for Copilot+ PCs. To quicly recap, the Recall feature takes snapshots of your ...

for Microsoft 365. Plus, while you’ll get to download the full app suite to one PC for lifelong use, you’ll eventually upgrade that device and have to purchase another license key to download ...

After the first quick-fire version of Microsoft's artificial intelligence function “Recall” had to be stopped shortly after launch, Microsoft has now made improvements and is making a new attempt.

Microsoft has solidified its plans for June, confirming an Xbox Games Showcase 2025 as well as an The Outer Worlds 2 Direct. Microsoft normally hosts a June showcase to reveal upcoming Xbox games ...

Weird OS: Microsoft regularly deprecates features in Windows, typically replacing them with improved alternatives or streamlining development. That's why its decision to drop a relatively new ...

One Microsoft executive has a more optimistic outlook, forecasting AI's dominance in coding within the next five years. Microsoft CTO Kevin Scott predicted that 95 percent of programming code will ...

B. Riley raised the firm’s price target on ClearPoint Neuro (CLPT) to $28 from $20 and keeps a Buy rating on the shares following a transfer of coverage. ClearPoint is a medical device company ...

In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on ClearPoint Neuro (CLPT – Research Report). The company’s shares closed yesterday at $13.25. Discover ...